Your browser doesn't support javascript.
loading
PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy.
Grandal, Beatriz; Mangiardi-Veltin, Manon; Laas, Enora; Laé, Marick; Meseure, Didier; Bataillon, Guillaume; El-Alam, Elsy; Darrigues, Lauren; Dumas, Elise; Daoud, Eric; Vincent-Salomon, Anne; Talagrand, Laure-Sophie; Pierga, Jean-Yves; Reyal, Fabien; Hamy, Anne-Sophie.
Afiliação
  • Grandal B; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, 75005 Paris, France.
  • Mangiardi-Veltin M; Department of Surgical Oncology, Institut Curie, University Paris, 75005 Paris, France.
  • Laas E; Department of Surgical Oncology, Institut Curie, University Paris, 75005 Paris, France.
  • Laé M; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, 75005 Paris, France.
  • Meseure D; Department of Surgical Oncology, Institut Curie, University Paris, 75005 Paris, France.
  • Bataillon G; Department of Pathology, Henri Becquerel Cancer Center, INSERM U1245, UniRouen Normandy University, 76038 Rouen, France.
  • El-Alam E; Department of Pathology, Institut Curie, University Paris, 75005 Paris, France.
  • Darrigues L; Department of Pathology, Institut Curie, University Paris, 75005 Paris, France.
  • Dumas E; Department of Pathology, Institut Curie, University Paris, 75005 Paris, France.
  • Daoud E; Department of Pathology, Institut Curie, University Paris, 75005 Paris, France.
  • Vincent-Salomon A; Department of Surgical Oncology, Institut Curie, University Paris, 75005 Paris, France.
  • Talagrand LS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, 75005 Paris, France.
  • Pierga JY; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, 75005 Paris, France.
  • Reyal F; Department of Pathology, Institut Curie, University Paris, 75005 Paris, France.
  • Hamy AS; Department of Surgical Oncology, Institut Curie, University Paris, 75005 Paris, France.
Cancers (Basel) ; 13(4)2021 Feb 11.
Article em En | MEDLINE | ID: mdl-33670162
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article